Expand MOLN Menu
MOLN MENU

MOLN Latest Press Releases

-- May 30, 2026 --

Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1 Globe Newswire 8:00 AM

-- May 26, 2026 --

Molecular Partners to Present at TD Cowen's 7th Annual Oncology Innovation Summit Globe Newswire 4:00 PM

-- May 12, 2026 --

Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317 Globe Newswire 4:00 PM

-- May 4, 2026 --

Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences Globe Newswire 1:00 AM

-- May 1, 2026 --

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling Globe Newswire 7:00 AM

-- April 19, 2026 --

Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712 Globe Newswire 12:00 PM

-- April 14, 2026 --

Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting Globe Newswire 4:00 PM

-- March 23, 2026 --

Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors Globe Newswire 9:00 AM

-- March 19, 2026 --

Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins' Amenability to Multiple Isotopes Globe Newswire 2:00 AM

-- March 17, 2026 --

Molecular Partners to Hold Three Poster Presentations at AACR 2026 Globe Newswire 4:30 PM

-- March 12, 2026 --

Molecular Partners Reports Highlights and Financial Results for Full Year 2025 Globe Newswire 4:00 PM

-- February 26, 2026 --

Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results Globe Newswire 1:00 AM
Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics Globe Newswire 1:00 AM

-- February 2, 2026 --

Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026 Globe Newswire 1:00 AM
Market Data Delayed 15 Minutes